home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Prostate Cancer Risk Variants

 
  April, 5 2007 8:22
your information resource in human molecular genetics
 
     
Several newly identified genetic variants on chromosome 8 are associated with increased risk of developing prostate cancer, according to three studies published online in Nature Genetics.

Last year scientists in Iceland reported that a variant on chromosome 8 is associated with elevated risk of prostate cancer. Three groups have now revisited this region on chromosome 8, and have found additional variants that independently contribute to prostate cancer susceptibility. One group, led by Kari Stefansson, reports that a second variant is associated with the disease in several populations. This variant is relatively uncommon in individuals of European descent, but quite common in African Americans, suggesting that it accounts for some of the higher risk for prostate cancer observed in individuals of African descent.

The second group, led by David Reich, identified this same variant, as well as five previously undescribed risk variants in populations representing five different ethnic backgrounds. Finally, the third group, led by Stephen Chanock, found one of the variants reported by the Broad study to be associated with elevated risk in five different populations.

According to Reich and colleagues, combinations of these risk variants could account for up to two-thirds of prostate cancer cases in African Americans, and up to one-third of cases in European Americans. The variants do not map to a particular gene, but each group speculates that collectively they could promote amplification of this entire region of chromosome 8, an event that is commonly observed in prostate tumours.

Author contacts:

Kari Stefansson (deCODE Genetics, Reykjavik, Iceland)
E-mail: kstefans@decode.is

David Reich (Broad Institute of Harvard and MIT, Cambridge, MA, USA)
E-mail: reich@genetics.med.harvard.edu

Additional contact for comment on Reich paper:

Brian Henderson (Keck School of Medicine, Los Angeles, CA, USA)
E-mail: Brian.Henderson@keck.usc.edu

Stephen Chanock (National Institutes of Health, Bethesda, MD, USA)
E-mail: chanocks@mail.nih.gov

Abstracts available online:
Paper 1.
Paper 2.
Paper 3.

(C) Nature Genetics press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.